Posted by Michael Wonder on 21 May 2021
Biosimilar bevacizumab on the PBS - information for health professionals and patients
21 May 2021 - A biosimilar brand of bevacizumab (Mvasi) will be listed on the PBS on 1 June 2021. Information about this listing, and about biosimilars, can be found on the Biosimilar Awareness web page. of the PBS website.
From 1 June 2021 Avastin will no longer be available on the PBS, and Mvasi will be the sole brand available on the PBS.
